Meticulous Research®, a leading global market research company, has released a report titled ‘Asia-Pacific Plasma Therapy Market, By Type (Pure Platelet-rich Plasma, Platelet-rich Fibrin), Application (Orthopedics, Dermatology, Cosmetology, Rheumatology, Ophthalmology, Stomatology), End User (Hospitals & Clinics, Research Institutes) – Forecast to 2030.’ This report indicates that the Asia-Pacific Plasma Therapy Market is projected to reach $214 million by 2030, with a CAGR of 13.4% from 2024 to 2030. The market growth is driven by rising healthcare expenditures, an increasing geriatric population, and a high incidence of accidents in the region. Additionally, conferences advocating for the use of platelet-rich plasma (PRP) and ongoing research in PRP therapy are expected to further enhance market growth. However, the stringent regulatory framework surrounding PRP usage poses significant challenges. Conversely, the expanding applications of PRP treatments and advancements in healthcare infrastructure across Asia-Pacific countries present substantial growth opportunities.
